Sue D Pedersen Selected Research

Sue D Pedersen Research Topics

11	Type 2 Diabetes Mellitus (MODY) 11/2023 - 06/2007
8	Obesity 11/2023 - 01/2018
8	Weight Loss (Weight Reduction) 01/2023 - 06/2007
6	Overweight 01/2022 - 06/2014
4	Nausea 01/2022 - 06/2014
2	Body Weight (Weight, Body) 11/2023 - 01/2023
1	Non-alcoholic Fatty Liver Disease 11/2023
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2023
1	Body Weight Changes 01/2023
1	Vomiting 01/2022
1	Constipation 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Weight Gain 01/2020
1	Stroke (Strokes) 01/2019
1	Chronic Renal Insufficiency 01/2019
1	Myocardial Infarction 01/2019
1	Gestational Diabetes (Gestational Diabetes Mellitus) 04/2013
1	Prediabetic State (Prediabetes) 04/2013
1	Diabetes Mellitus 06/2007

7	semaglutideIBA 01/2023 - 01/2018
3	Glucagon-Like Peptide-1 Receptor AgonistsIBA 11/2023 - 01/2018
3	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 06/2014
3	Liraglutide FDA Link 12/2021 - 01/2018
3	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021 - 06/2014
3	Insulin (Novolin)FDA Link 01/2020 - 06/2007
2	Glucagon-Like Peptide-1 ReceptorIBA 11/2023 - 01/2023
2	cagrilintideIBA 01/2023 - 12/2021
2	oxidized low density lipoproteinIBA 01/2021 - 01/2016
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2020 - 06/2007
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 11/2023
1	Islet Amyloid PolypeptideIBA 01/2023
1	Metformin (Glucophage)FDA LinkGeneric 01/2023
1	tirzepatideIBA 01/2023
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2023
1	EstersIBA 01/2021
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	eicosapentaenoic acid ethyl esterIBA 01/2021
1	GhrelinIBA 06/2014
1	Blood Glucose (Blood Sugar)IBA 04/2013